Xeltis’ restorative heart valves are the focus of two presentations at the EuroPCR meeting in Paris.

Prof. Martin B. Leon, Columbia University Medical Center, and Prof. Patrick Serruys, Imperial College London, are providing an outline on the developments of Xeltis’ restorative aortic valve, currently in preclinical trials, and its potential to advance to clinical phase.

Xeltis was included in the PCR Innovators Day program for the third year as Professor Leon presented at the Theatre Havane, Palais des Congrès. Professor Serruys will be among the speakers of the “Innovations in TAVI – device parade” session on May 24 at 9:25am, room 252B.

Click here for more information on EuroPCR.